Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 262 followers
Latest posts
Last updated about 9 hours ago
Human medicines European public assessment report (EPAR): Levetiracetam Accord, levetiracetam, Date of authorisation: 03/10/2011, Revision: 19, Status: Authorised
about 9 hours ago
Human medicines European public assessment report (EPAR): Levetiracetam Accord, levetiracetam, Date of...
Human medicines European public assessment report (EPAR): Qtern, saxagliptin,dapagliflozin, Date of authorisation: 15/07/2016, Revision: 14, Status: Authorised
about 9 hours ago
Human medicines European public assessment report (EPAR): Qtern, saxagliptin,dapagliflozin, Date of authorisation...
Human medicines European public assessment report (EPAR): Filspari, Sparsentan, Date of authorisation: 19/04/2024, Revision: 2, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Filspari, Sparsentan, Date of authorisation...
Human medicines European public assessment report (EPAR): Retsevmo, selpercatinib, Date of authorisation: 11/02/2021, Revision: 16, Status: Authorised
about 12 hours ago
Human medicines European public assessment report (EPAR): Retsevmo, selpercatinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Quviviq, daridorexant, Date of authorisation: 29/04/2022, Revision: 10, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Quviviq, daridorexant, Date of authorisation...
Human medicines European public assessment report (EPAR): Winlevi, clascoterone, Status: Opinion
about 15 hours ago
Human medicines European public assessment report (EPAR): Winlevi, clascoterone, Status: Opinion
Human medicines European public assessment report (EPAR): Hyrimoz, adalimumab, Date of authorisation: 26/07/2018, Revision: 16, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Hyrimoz, adalimumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Date of authorisation: 26/07/2018, Revision: 17, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Zilbrysq, Zilucoplan, Date of authorisation: 01/12/2023, Revision: 2, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Zilbrysq, Zilucoplan, Date of authorisation...
Human medicines European public assessment report (EPAR): Xenleta, lefamulin, Date of authorisation: 27/07/2020, Revision: 2, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Xenleta, lefamulin, Date of authorisation...
Human medicines European public assessment report (EPAR): Shingrix, herpes zoster vaccine (recombinant, adjuvanted), Date of authorisation: 21/03/2018, Revision: 11, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Shingrix, herpes zoster vaccine (recombinant...
Human medicines European public assessment report (EPAR): Hympavzi, marstacimab, Date of authorisation: 18/11/2024, Revision: 1, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Hympavzi, marstacimab, Date of authorisation...